Key result
Acute pulmonary embolism carries a <5% risk of death in stable patients and a cumulative recurrence risk of approximately 30% at 10 years.
While initial mortality is low in stable patients with pulmonary embolism, there is a substantial long-term cumulative risk of recurrence reaching approximately 30% at 10 years.
Answers are grounded in this paper and cite their sources.
Supports extended anticoagulation decisions in stable PE; leaves open optimal duration and risk-stratification trials.
The risk of death after an episode of acute pulmonary embolism is less than 5%, provided that the patient is hemodynamically stable and free of major underlying disease. In unselected patients, pulmonary embolism and recurrent disease are responsible for a minority of deaths. Recurrent thromboembolism occurs in less than 5% of patients receiving anticoagulant therapy. The recurrence rate is higher during the first few months after termination of anticoagulant therapy, declining thereafter. At 10 years after the initial episode, the cumulative risk of recurrence is approximately 30%. In patients with a history of pulmonary embolism, recurrences are more likely to take the form of a new pulmonary embolism than deep venous thrombosis. Chronic thromboembolic pulmonary hypertension occurs in less than 5% of patients after pulmonary embolism, but most patients have persistent perfusion defects on lung scans several months after the initial episode. The significance of these findings remains unclear.
No takes yet. Share an insight, caveat, or question.
Meyer et al. (2008) conducted a review in Acute pulmonary embolism. Acute pulmonary embolism was evaluated. Acute pulmonary embolism carries a <5% risk of death in stable patients and a cumulative recurrence risk of approximately 30% at 10 years.
Synapse has enriched 10 related papers. Consider them for comparative context: